Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changsu Han

Showing results (71-80 of 276) with videos related to

Pageof 28
Sort By:
Psychiatry Research|July 7, 2018
Emotional labor and depressive mood in service and sales workers: Interactions with gender and job autonomyKyu-Man Han, Cheolmin Shin, Ho-Kyoung Yoon, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|December 16, 2014
Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depressionHyun-Ghang Jeong, Young-Hoon Ko, So-Young Oh, et al.
European Neurology|May 3, 2013
Increased carotid intima-media thickness and plasma homocysteine levels predict cardiovascular and all-cause death: a population-based cohort studyJin-Man Jung, Do Young Kwon, Changsu Han, et al.
Life (Basel, Switzerland)|May 27, 2023
Associations between Pharmacological Treatment Patterns during the Initial Treatment Period and the Relapse or Recurrence of Anxiety Disorders: A Nationwide Retrospective Cohort StudyJunhyung Kim, Changsu Han, Moon-Soo Lee, et al.
Metabolic Syndrome and Related Disorders|November 26, 2009
Low levels of plasma agmatine in the metabolic syndromeInho Jo, Changsu Han, Sangmee Ahn Jo, et al.
Expert Opinion on Pharmacotherapy|January 22, 2010
Paroxetine mesylate: comparable to paroxetine hydrochloride?Chi-Un Pae, Aayushman Misra, Byung-Joo Ham, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopauseChi-Un Pae, Min-Hyeon Park, David M Marks, et al.
Psychiatry Investigation|April 14, 2015
Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of actionSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation StudyChi-Un Pae, Changsu Han, Won-Myong Bahk, et al.
International Clinical Psychopharmacology|October 11, 2013
Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment settingChi-Un Pae, Sheng-Min Wang, Changsu Han, et al.
Pageof 28

Showing results (71-80 of 276) with videos related to

Sort By:
Pageof 28
Psychiatry Research|July 7, 2018
Emotional labor and depressive mood in service and sales workers: Interactions with gender and job autonomyKyu-Man Han, Cheolmin Shin, Ho-Kyoung Yoon, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|December 16, 2014
Effect of Korean Red Ginseng as an adjuvant treatment for women with residual symptoms of major depressionHyun-Ghang Jeong, Young-Hoon Ko, So-Young Oh, et al.
European Neurology|May 3, 2013
Increased carotid intima-media thickness and plasma homocysteine levels predict cardiovascular and all-cause death: a population-based cohort studyJin-Man Jung, Do Young Kwon, Changsu Han, et al.
Life (Basel, Switzerland)|May 27, 2023
Associations between Pharmacological Treatment Patterns during the Initial Treatment Period and the Relapse or Recurrence of Anxiety Disorders: A Nationwide Retrospective Cohort StudyJunhyung Kim, Changsu Han, Moon-Soo Lee, et al.
Metabolic Syndrome and Related Disorders|November 26, 2009
Low levels of plasma agmatine in the metabolic syndromeInho Jo, Changsu Han, Sangmee Ahn Jo, et al.
Expert Opinion on Pharmacotherapy|January 22, 2010
Paroxetine mesylate: comparable to paroxetine hydrochloride?Chi-Un Pae, Aayushman Misra, Byung-Joo Ham, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopauseChi-Un Pae, Min-Hyeon Park, David M Marks, et al.
Psychiatry Investigation|April 14, 2015
Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of actionSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation StudyChi-Un Pae, Changsu Han, Won-Myong Bahk, et al.
International Clinical Psychopharmacology|October 11, 2013
Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment settingChi-Un Pae, Sheng-Min Wang, Changsu Han, et al.
Pageof 28